From: The prognostic impact of Wilms tumor-1 polymorphism (rs16754) and human myeloid inhibitory C-type lectin-like receptor expression in cytogenetically normal-acute myeloid leukemia
Parameters
AML cases (N = 63)
Outcome
N (%)
Response at 28 days:
Died
17 (27.0)
CR
20 (31.7)
PR
26 (41.3)
Response at 6 months:
26 (41.3 )
Relapse
11 (17.4)
Response at 24 months
Died or relapse
37 (58.7)